Recently added articles from Psychopharmacology Educational Updates (PsychEd Up):
Selective histamine H1 antagonism: Part II.(Essential Psychopharmacology)
Jul 01, 2009; ... Issue Antihistamines have been widely used to treat insomnia and may have obtained a bad reputation in the past. The clinical difference between selective and nonselective H1 antagonism is not widely known. Action The therapeutic benefits of selective H1 ...
New treatments in Parkinson's disease.(Second Messenger)
Jul 01, 2009; ... Issue Parkinson's disease affects more than one million Americans aged 55 and over. Patients with Parkinson's disease often have comorbid psychiatric disorders, and the treatment of these patients can be challenging. Action In order to properly treat ...
Depression and chronic medical illness: why psychiatrists should care.(Invited Insights)
Jun 01, 2009; ... Issue Depression is one of the most prevalent psychiatric disorders and when co-occurring with medical illnesses likely creates a vicious circle in which each separate ailment makes treatment outcomes worse for the others. Action A better assessment and ...
Paliperidone.(Tips and Pearls)
Jun 01, 2009 ... Brands Invega Class Atypical antipsychotic (serotonin-dopamine antagonist; second-generation antipsychotic; also a mood stabilizer) Dosing Formulation: Tablet (extended-release) 3 mg, 6 mg, 9 mg Dosage Range: ...
The sigma enigma: can sigma receptors provide a novel target for disorders of mood and cognition?(Essential PsychopharmaSTAHLogy)(Report)
May 01, 2009; ... Issue Evidence currently suggests that [sigma] 1 and [sigma] 2 receptors both mediate important functional and behavioral actions in the central nervous system and serve as novel targets for treatment of depression, cognitive disorders, cocaine abuse, and stroke. ...